A type of artificial intelligence called machine learning can help predict which patients will develop diabetes, according to an ENDO 2020 abstract that will be published in a special supplemental section of the Journal of the Endocrine Society.
Diabetes is linked to increased risks of severe health problems, including heart disease and cancer. Preventing diabetes is essential to reduce the risk of illness and death. “Currently we do not have sufficient methods for predicting which generally healthy individuals will develop diabetes,” said lead author Akihiro Nomura, M.D., Ph.D., of the Kanazawa University Graduate School of Medical Sciences in Kanazawa, Japan.
The researchers investigated the use of a type of artificial intelligence called machine learning in diagnosing diabetes. Artificial intelligence (AI) is the development of computer systems able to perform tasks that normally require human intelligence. Machine learning is a type of AI that enables computers to learn without being explicitly programmed. With each exposure to new data, a machine-learning algorithm grows increasingly better at recognizing patterns over time.
“Using machine learning, it could be possible to precisely identify high-risk groups of future diabetes patients better than using existing risk scores,” Nomura said. “In addition, the rate of visits to healthcare providers might be improved to prevent future onset of diabetes.”
Nomura and colleagues analyzed 509,153 nationwide annual health checkup records from 139,225 participants from 2008 to 2018 in the city of Kanazawa. Among them, 65,505 participants without diabetes were included.
The data included physical exams, blood and urine tests and participant questionnaires. Patients without diabetes at the beginning of the study who underwent more than two annual health checkups during this period were included. New cases of diabetes were recorded during patients’ checkups.
The researchers identified a total of 4,696 new diabetes patients (7.2%) in the study period. Their trained computer model predicted the future incidence of diabetes with an overall accuracy of 94.9%.
Nomura says he next plans to perform clinical trials to assess the effectiveness of using statins to treat groups of patients identified by the machine learning model as being at high risk of developing diabetes.
The Endocrine Society canceled its annual meeting, ENDO 2020, amid concerns about COVID-19. Visit our online newsroom for more information on accepted abstracts, which will be published in a special supplemental section of the Journal of the Endocrine Society.
About Endocrine Society
Endocrinologists are at the core of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, and hormone-related cancers. The Endocrine Society is the world’s oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.
The Society has more than 18,000 members, including scientists, physicians, educators, nurses, and students in 122 countries. To learn more about the Society and the field of endocrinology, visit our site at www.endocrine.org. Follow us on X (formerly Twitter) at @TheEndoSociety and @EndoMedia.
Colleen Williams Senior Communications Manager, Public Relations Phone: (202)-971-3611 [email protected]
Jenni Glenn Gingery Director, Communications and Media Relations Phone: (202)-971-3655 [email protected]
The Endocrine News podcast brings you the latest research and clinical advances from experts in the field, whether you are in your car, office, or out for a run.
Our top-ranked peer-reviewed journals are among the first to publish major developments and discovery milestones.
